Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Imidazoquinolines as dual lipid kinase and mTOR inhibitors

Imidazoquinolines as dual lipid kinase and mTOR inhibitors

US Patent 9370508 · Granted Jun 21, 2016

Estimated economic value: $19,235,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds and compositions for inhibiting the activity of HIF2-alpha and their m2025
Treatment of cancer using humanized anti-BCMA chimeric antigen receptor2025
Treatment of cancer using a CD123 chimeric antigen receptor2023
Regulatable chimeric antigen receptor2023
Inhibitors of TRPC62022
Phosphoglycerate kinase 1 (PGK) promoters and methods of use for expressing chim2022
Anti-BCMA chimeric antigen receptor2021
Disinfectant composition2020
Biomarkers predictive of therapeutic responsiveness to chimeric antigen receptor2020
Treatment of cancer using a CD123 chimeric antigen receptor2020
Pharmaceutical combination of everolimus with dactolisib2020
Treatment of cancer using a CLL-1 chimeric antigen receptor2020